IN2014DE01467A - - Google Patents
Info
- Publication number
- IN2014DE01467A IN2014DE01467A IN1467DE2014A IN2014DE01467A IN 2014DE01467 A IN2014DE01467 A IN 2014DE01467A IN 1467DE2014 A IN1467DE2014 A IN 1467DE2014A IN 2014DE01467 A IN2014DE01467 A IN 2014DE01467A
- Authority
- IN
- India
- Prior art keywords
- hot
- melt
- temperature
- drug
- melt extrusion
- Prior art date
Links
- ZUAAPNNKRHMPKG-UHFFFAOYSA-N acetic acid;butanedioic acid;methanol;propane-1,2-diol Chemical compound OC.CC(O)=O.CC(O)CO.OC(=O)CCC(O)=O ZUAAPNNKRHMPKG-UHFFFAOYSA-N 0.000 abstract 5
- 238000009474 hot melt extrusion Methods 0.000 abstract 5
- 229940079593 drug Drugs 0.000 abstract 4
- 239000003814 drug Substances 0.000 abstract 4
- 239000012943 hotmelt Substances 0.000 abstract 4
- -1 hydroxypropoxy Chemical group 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 238000006467 substitution reaction Methods 0.000 abstract 2
- 230000009849 deactivation Effects 0.000 abstract 1
- 238000002844 melting Methods 0.000 abstract 1
- 230000008018 melting Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000001694 spray drying Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B11/00—Preparation of cellulose ethers
- C08B11/193—Mixed ethers, i.e. ethers with two or more different etherifying groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B11/00—Preparation of cellulose ethers
- C08B11/20—Post-etherification treatments of chemical or physical type, e.g. mixed etherification in two steps, including purification
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B13/00—Preparation of cellulose ether-esters
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/20—Compounding polymers with additives, e.g. colouring
- C08J3/201—Pre-melted polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/08—Cellulose derivatives
- C08L1/32—Cellulose ether-esters
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
- C08J2301/08—Cellulose derivatives
- C08J2301/32—Cellulose ether-esters
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013116836 | 2013-06-03 | ||
| JP2013246178 | 2013-11-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DE01467A true IN2014DE01467A (cg-RX-API-DMAC7.html) | 2015-07-24 |
Family
ID=50842156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1467DE2014 IN2014DE01467A (cg-RX-API-DMAC7.html) | 2013-06-03 | 2014-06-03 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10646573B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3006049B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6126555B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR102228157B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN105283203B (cg-RX-API-DMAC7.html) |
| IN (1) | IN2014DE01467A (cg-RX-API-DMAC7.html) |
| PT (2) | PT3006049T (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014196519A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3006049B1 (en) | 2013-06-03 | 2018-02-28 | Shin-Etsu Chemical Co., Ltd. | Composition for hot melt extrusion and method for producing a hot melt extruded product |
| JP6203702B2 (ja) | 2014-11-18 | 2017-09-27 | 信越化学工業株式会社 | ヒプロメロース酢酸エステルコハク酸エステルを用いたスプレードライ用溶液及び固体分散体の製造方法 |
| US10577348B2 (en) | 2014-12-18 | 2020-03-03 | Merck Sharp & Dohme Corp. | (S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations |
| KR20180008524A (ko) * | 2015-05-15 | 2018-01-24 | 다우 글로벌 테크놀로지스 엘엘씨 | 초고분자량 및 저점도의 에스테르화된 셀룰로오스 에테르의 제조 방법 |
| JP6737810B2 (ja) * | 2015-05-15 | 2020-08-12 | ダウ グローバル テクノロジーズ エルエルシー | 高分子量のエステル化セルロースエーテルを調製するプロセス |
| KR20180036724A (ko) * | 2015-07-28 | 2018-04-09 | 다우 글로벌 테크놀로지스 엘엘씨 | 에스테르화된 셀룰로오스 에테르의 분산물을 생성하는 방법 |
| WO2018170083A1 (en) | 2017-03-17 | 2018-09-20 | Dow Global Technologies Llc | Process for recovering an esterified cellulose ether from a reaction product mixture |
| KR20190125334A (ko) | 2017-03-17 | 2019-11-06 | 다우 글로벌 테크놀로지스 엘엘씨 | 반응 생성 혼합물로부터 에스테르화 셀룰로스 에테르를 회수하는 공정 |
| MX2019010207A (es) | 2017-03-17 | 2019-10-09 | Dow Global Technologies Llc | Proceso para recuperar un eter de celulosa esterificado a partir de una mezcla de producto de reaccion. |
| US20180282527A1 (en) * | 2017-03-30 | 2018-10-04 | Shin-Etsu Chemical Co., Ltd. | Injection molding composition containing hypromellose acetate succinate and method for producing same |
| CN109078186B (zh) * | 2017-06-14 | 2021-09-03 | 江苏恒瑞医药股份有限公司 | 一种胃漂浮组合物及其制备方法 |
| TR201722852A2 (tr) * | 2017-12-29 | 2019-07-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Mesalazi̇ni̇n oral farmasöti̇k kompozi̇syonlari |
| WO2020131801A1 (en) | 2018-12-18 | 2020-06-25 | DDP Specialty Electronic Materials US, Inc. | A sustained release composition comprising a hydroxypropyl methylcellulose acetate succinate |
| JP7050714B2 (ja) | 2019-04-04 | 2022-04-08 | 信越化学工業株式会社 | 腸溶性コーティング用組成物及び固形製剤の製造方法 |
| JP7273691B2 (ja) | 2019-11-01 | 2023-05-15 | 信越化学工業株式会社 | ヒドロキシプロピルメチルセルロースフタレートの製造方法 |
| JP7252882B2 (ja) * | 2019-11-01 | 2023-04-05 | 信越化学工業株式会社 | ヒドロキシプロピルメチルセルロースアセテートサクシネートの製造方法 |
| WO2021118915A1 (en) | 2019-12-09 | 2021-06-17 | Nutrition & Biosciences Usa 1, Llc | Hydroxypropyl alkyl cellulose acetate succinate heteropolymers |
| EP4196096A1 (en) | 2020-08-13 | 2023-06-21 | Alfred E. Tiefenbacher (GmbH & Co. KG) | Gastro-resistant high-strength formulation containing posaconazole |
| JP7399060B2 (ja) * | 2020-10-01 | 2023-12-15 | 信越化学工業株式会社 | ヒドロキシプロピルメチルセルロースアセテートサクシネートの製造方法 |
| EP4091604B1 (en) | 2021-11-25 | 2024-04-03 | Alfred E. Tiefenbacher (GmbH & Co. KG) | Granules containing posaconazole |
| CN115581678B (zh) * | 2022-11-04 | 2023-09-12 | 北京鑫开元医药科技有限公司 | 一种瑞派替尼片组合物及其制备方法 |
| CN115651085B (zh) * | 2022-11-14 | 2023-11-17 | 乳源东阳光药业有限公司 | 一种醋酸羟丙甲纤维素琥珀酸酯的纯化方法 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3852421A (en) * | 1970-03-23 | 1974-12-03 | Shinetsu Chemical Co | Excipient and shaped medicaments prepared therewith |
| JPS5951562B2 (ja) | 1977-10-25 | 1984-12-14 | 信越化学工業株式会社 | セルロ−スエ−テルの酸性サクシニルおよび脂肪族モノアシル混成エステルの製造方法 |
| US4226981A (en) * | 1977-09-28 | 1980-10-07 | Shin-Etsu Chemical Co., Ltd. | Ether-ester derivatives of cellulose and their applications |
| US4266981A (en) | 1978-03-08 | 1981-05-12 | Purdue Research Corporation | Process for recovering and utilizing cellulose using sulfuric acid |
| DE19504832A1 (de) * | 1995-02-14 | 1996-08-22 | Basf Ag | Feste Wirkstoff-Zubereitungen |
| AR038375A1 (es) | 2002-02-01 | 2005-01-12 | Pfizer Prod Inc | Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo |
| WO2003077827A1 (en) | 2002-03-19 | 2003-09-25 | Nippon Shinyaku Co., Ltd. | Process for producing drug solid dispersion |
| KR100454394B1 (ko) | 2002-03-27 | 2004-10-26 | 이원희 | 맥파검출장치 |
| JP4344914B2 (ja) * | 2003-02-28 | 2009-10-14 | 信越化学工業株式会社 | アルカリ溶解性カルボン酸エステル系セルロース誘導体及び該誘導体からなるフィルム |
| DE602005010074D1 (de) | 2004-05-28 | 2008-11-13 | Pfizer Prod Inc | Pharmazeutische zusammensetzungen mit verbesserter leistung enthaltend ein hpmca polymer |
| JPWO2007029660A1 (ja) * | 2005-09-06 | 2009-03-19 | アステラス製薬株式会社 | 腸溶性基剤が表面に吸着した難溶性薬物の微小粒子 |
| JP5576922B2 (ja) * | 2006-04-20 | 2014-08-20 | 信越化学工業株式会社 | 腸溶性固体分散体を含んでなる固形製剤 |
| JP5070618B2 (ja) * | 2006-06-16 | 2012-11-14 | トーアエイヨー株式会社 | 腸溶性顆粒剤及びその製造方法 |
| JP5052051B2 (ja) * | 2006-06-16 | 2012-10-17 | トーアエイヨー株式会社 | 腸溶性顆粒剤及びその製造方法 |
| CN101686994B (zh) | 2006-10-20 | 2013-05-01 | 陶氏环球技术公司 | 水溶性纤维素衍生物制备用于预防或治疗代谢综合征的药物等的用途 |
| AU2009236289B2 (en) * | 2008-04-15 | 2014-08-21 | Merck Sharp & Dohme Corp. | Oral pharmaceutical compositions in a solid dispersion comprising preferably posaconazole and HPMCAS |
| CA2720851A1 (en) | 2008-04-15 | 2009-10-22 | Schering Corporation | Oral pharmaceutical compositions in a molecular solid dispersion |
| EP2354825B1 (en) | 2010-02-03 | 2015-07-15 | Tyco Electronics Nederland B.V. | Enclosure assembly for a connector, strain relief element, and method |
| WO2011159626A1 (en) | 2010-06-14 | 2011-12-22 | Bend Research, Inc. | Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution |
| US8409560B2 (en) | 2011-03-08 | 2013-04-02 | Zalicus Pharmaceuticals Ltd. | Solid dispersion formulations and methods of use thereof |
| KR20140011366A (ko) * | 2011-03-08 | 2014-01-28 | 잘리커스 파마슈티컬즈 리미티드 | 고체 분산체 제형 및 그의 이용방법 |
| US20120251588A1 (en) * | 2011-03-30 | 2012-10-04 | Miyuki Fukasawa | Coating Composition, Solid Preparation Coated Therewith, and Method for Preparing Solid Preparation |
| JP2013116836A (ja) | 2011-12-02 | 2013-06-13 | Sharp Corp | シリコン端材の再利用方法並びに原料シリコン、多結晶シリコン材料及び多結晶シリコン太陽電池の製造方法 |
| DE102012010430A1 (de) | 2012-05-29 | 2013-12-05 | Krohne Ag | Durchflussmessgerät |
| KR102138544B1 (ko) | 2012-08-24 | 2020-07-28 | 다우 글로벌 테크놀로지스 엘엘씨 | 신규한 하이드록시알킬 메틸 셀룰로즈 아세테이트 석시네이트 |
| EP3006049B1 (en) | 2013-06-03 | 2018-02-28 | Shin-Etsu Chemical Co., Ltd. | Composition for hot melt extrusion and method for producing a hot melt extruded product |
-
2014
- 2014-06-03 EP EP14806945.3A patent/EP3006049B1/en active Active
- 2014-06-03 IN IN1467DE2014 patent/IN2014DE01467A/en unknown
- 2014-06-03 US US14/892,421 patent/US10646573B2/en active Active
- 2014-06-03 JP JP2014114900A patent/JP6126555B2/ja active Active
- 2014-06-03 PT PT148069453T patent/PT3006049T/pt unknown
- 2014-06-03 EP EP14170863.6A patent/EP2810660B1/en active Active
- 2014-06-03 WO PCT/JP2014/064711 patent/WO2014196519A1/ja not_active Ceased
- 2014-06-03 JP JP2015521450A patent/JP6007322B2/ja active Active
- 2014-06-03 US US14/294,258 patent/US10016508B2/en active Active
- 2014-06-03 CN CN201480030211.8A patent/CN105283203B/zh active Active
- 2014-06-03 KR KR1020157034116A patent/KR102228157B1/ko active Active
- 2014-06-03 CN CN201410242677.6A patent/CN104208713B/zh active Active
- 2014-06-03 PT PT141708636T patent/PT2810660T/pt unknown
- 2014-06-03 KR KR1020140067370A patent/KR101918327B1/ko active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN105283203A (zh) | 2016-01-27 |
| US10016508B2 (en) | 2018-07-10 |
| EP3006049B1 (en) | 2018-02-28 |
| KR20140142173A (ko) | 2014-12-11 |
| WO2014196519A1 (ja) | 2014-12-11 |
| JP6007322B2 (ja) | 2016-10-12 |
| JPWO2014196519A1 (ja) | 2017-02-23 |
| CN104208713B (zh) | 2018-04-27 |
| KR101918327B1 (ko) | 2018-11-13 |
| EP3006049A4 (en) | 2017-02-22 |
| KR102228157B1 (ko) | 2021-03-17 |
| CN105283203B (zh) | 2018-12-28 |
| PT3006049T (pt) | 2018-03-20 |
| US20140357681A1 (en) | 2014-12-04 |
| CN104208713A (zh) | 2014-12-17 |
| KR20160015234A (ko) | 2016-02-12 |
| PT2810660T (pt) | 2017-08-16 |
| JP6126555B2 (ja) | 2017-05-10 |
| JP2015127316A (ja) | 2015-07-09 |
| US10646573B2 (en) | 2020-05-12 |
| EP2810660A1 (en) | 2014-12-10 |
| EP2810660B1 (en) | 2017-07-26 |
| EP3006049A1 (en) | 2016-04-13 |
| US20160095928A1 (en) | 2016-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DE01467A (cg-RX-API-DMAC7.html) | ||
| HUE066810T2 (hu) | Stabilizált fluorolefin kompozíciók és eljárás elõállításukra, tárolásukra és felhasználásukra | |
| AU2019268159A1 (en) | Systems and methods for synthesizing chemical products, including active pharmaceutical ingredients | |
| EP4449901A3 (en) | Capsule for tobacco industry product | |
| IN2014DE02197A (cg-RX-API-DMAC7.html) | ||
| HUE038367T2 (hu) | Új indazolkarboxamidok, eljárás ezek elõállítására, ezeket tartalmazó gyógyszerkészítmények, valamint ezek alkalmazása gyógyszerkészítmények elõállítására | |
| MX361723B (es) | Dihidrato de un compuesto de benzotiofeno o de una sal del mismo y proceso para producir el mismo. | |
| EP3283470A4 (en) | Processes for producing 2,5-furandicarboxylic acid and derivatives thereof and polymers made therefrom | |
| EP2898948A4 (en) | GLYCERINE DEHYDRATION CATALYST, METHOD OF MANUFACTURING THEREOF, AND METHOD FOR THE PRODUCTION OF ACROLEINE | |
| EP3315499A4 (en) | CRYSTAL OF (6S,9aS)-N-BENZYL-6-[(4-HYDROXYPHENYL)METHYL]- 4,7-DIOXO-8-({6-[3-(PIPERAZIN-1-YL)AZETIDIN-1-YL]PYRIDIN- 2-YL}METHYL)-2-(PROP-2-EN-1-YL)-OCTAHYDRO-1H-PYRAZINO[2,1-c][1,2,4]TRIAZINE-1-CARBOXAMIDE COMPOUND | |
| WO2015019198A3 (en) | High potency pancreatin pharmaceutical compositions | |
| ZA201600415B (en) | Novel derivatives of indole and pyrrole, method for the production thereof and pharmaceutical compositions containing same | |
| IN2013CH02295A (cg-RX-API-DMAC7.html) | ||
| PH12021550413A1 (en) | Vitamin d pediatric dosage forms, methods of making and using | |
| IN2014DE03239A (cg-RX-API-DMAC7.html) | ||
| SA520411635B1 (ar) | A2a مشتق حلقي مدمج كمثبط مستقبل | |
| TWI799564B (zh) | 用於生產正丁醇、異丁醇及2-烷基烷醇之方法 | |
| SG11202105995QA (en) | Co-crystal of ketoprofen, compositions comprising the same, process of producing the same, and uses thereof | |
| WO2019240699A3 (en) | Tablet formulations comprising metformin and sitagliptin processed with hot-melt extrusion | |
| SMP201500110B (it) | Prodotto alimentare ripieno, nonche' metodo di produzione di tale prodotto alimentare | |
| WO2014160143A3 (en) | Isatin compounds, compositions and methods for treatment of degenerative diseases and disorders | |
| MX2021003908A (es) | Polipeptidos de accion prolongada y metodos para su produccion y administracion. | |
| WO2016161988A3 (zh) | 一种含有球形硫酸氢氯吡格雷i晶型的药物组合物及其制备方法 | |
| IN2013MU03704A (cg-RX-API-DMAC7.html) | ||
| IN2013MU03422A (cg-RX-API-DMAC7.html) |